• For Institutions

  • Download
  • Help
  • About

longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Nov11
Editas Medicine released FY2025 9 Months Earnings on November 10, 2025 (EST) with actual revenue of USD 15.78 M and EPS of USD -1.8255
04:00
Editas Medicine released FY2025 Q3 earnings on November 10 (EST), actual revenue USD 7.543 M (forecast USD 4.945 M), actual EPS USD -0.2787 (forecast USD -0.3121)
04:00
Oct6
Editas Medicine to Report CRISPR Gene Editing Drug Data at ESGCT Conference
13:00
Aug13
Editas Medicine released FY2025 Semi-Annual earnings on August 12 (EST), actual revenue USD 8.236 M, actual EPS USD -1.5443
03:00
Editas Medicine released FY2025 Q2 earnings on August 12 (EST), actual revenue USD 3.578 M (forecast USD 1.805 M), actual EPS USD -0.6306 (forecast USD -0.3836)
03:00
Jul3
Editas Medicine Showcases Progress in Gene Editing for Beta Thalassemia and Sickle Cell Disease
13:20

Schedules & Filings

Schedules
Filings
Nov10
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 7.543 M, Net Income -25.12 M, EPS -0.2787

Aug12
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 3.578 M, Net Income -53.24 M, EPS -0.6306

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 4.658 M, Net Income -76.09 M, EPS -0.9161

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
MSOX
7.940
+107.85%
+4.120
YCBD
1.200
+90.17%
+0.569
THH
15.520
+57.72%
+5.680
WEED
25.325
+55.65%
+9.055
NCI
1.920
+54.84%
+0.680
CNBS
34.820
+54.57%
+12.293
MSOS
5.800
+54.26%
+2.040
CGC
1.740
+53.98%
+0.610
RYM
23.800
+47.73%
+7.690
TLRY
12.150
+44.13%
+3.720
View More